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Type 2 diabetes (T2D) and ageing have well documented eﬀects on every organ in the body. In T2D the autonomic nervous system
is impaired due to damage to neurons, sensory receptors, synapses and the blood vessels. This paper will concentrate on how
autonomic impairment alters normal daily activities. Impairments include the response of the blood vessels to heat, sweating, heat
transfer, whole body heating, orthostatic intolerance, balance, and gait. Because diabetes is more prevalent in older individuals,
the eﬀects of ageing will be examined. Beginning with endothelial dysfunction, blood vessels have impairment in their ability to
vasodilate. With this and synaptic damage, the autonomic nervous system cannot compensate for eﬀectors such as pressure on
and heating of the skin. This and reduced ability of the heart to respond to stress, reduces autonomic orthostatic compensation.
Diminished sweating causes the skin and core temperature to be high during whole body heating. Impaired orthostatic tolerance,
impaired vision and vestibular sensing, causes poor balance and impaired gait. Overall, people with T2D must be made aware and
counseled relative to the potential consequence of these impairments.
1.Introduction
There is a natural senescence of the nervous system with
aging [1, 2]. This has a direct impact on autonomic function
that has been observed in a number of diﬀerent ways. For
example, there is a reduction in endothelial cell function due
toimpairmentinthereleaseofvasodilatorsubstancessuchas
nitric oxide and prostacyclin [3–5]. This hasthe overalleﬀect
of reducing blood ﬂow to all tissues in the body such as skin
[6,7],synapses[8],andneurons[9,10].Impairedcirculation
and high levels of free radicals found in older people and
people with diabetes [11–13] and glycosylation end products
in the cells [14] cause reduced synaptic activity [8], neuronal
death [3], and decreased baroreceptor response with age but
little change in baroreceptor sensitivity [15]. When coupled
withhardeningofthearteries,thisaccountsforanincreasein
blood pressure, reduced orthostatic tolerance, and a general
sluggishness in the autonomic nervous system to respond to
environmental stressors associated with aging [15].
Type 2 diabetes exacerbates the normal senescence of
the cardiovascular system with aging [16, 17]. For example,
when looking at the response to vascular occlusion, in
relation to age, with greater age there is a reduction in the
responseofthecirculationtovascularocclusion[18–20].For
individuals with diabetes, the reduction in blood ﬂow with
each year of age is the same but at a much lower baseline
level. Thus, in many ways, the eﬀect of aging and diabetes ar
synergistic in reducing cardiovascular function with aging.
However, there are also diﬀerences which will be discussed
below. This paper will illustrate how autonomic dysfunction
associated with aging and diabetes aﬀects activities of daily
life. The topics that will be reviewed are the response to local
pressure, contrast baths, global heating, local heating, exer-
cise, orthostatic tolerance, balance, and gait and how these
are inﬂuenced by diabetes. All of these activities are common
activities accomplished by individuals in their normal daily
lives.
2.The VascularEndothelialCell and
Age and Diabetes
At its simplest level, ageing and diabetes both cause damage
to vascular endothelial cells in the body. Since blood vessels2 Experimental Diabetes Research
provide nutrients for neurons, synapses, and other tissues in
the body, endothelial dysfunction has a major impact on the
autonomic nervous system [21–24]. A major complicating
factor is free radicals which also damage blood ﬂow to tissues
and increase both with ageing and diabetes [25]. Thus it
is appropriate to start any discussion of autonomic damage
and its eﬀects on the body with a discussion of endothelial
dysfunction.
In early stages of diabetes, the insulin receptor becomes
defective on cells [26] .T h ed e f e c ti sb e l i e v e dt ob ei nt h e
transduction after the binding of insulin to the activation
of Phosphatidylinositol 3-kinase (PI3K) [27]. This signaling
pathway is responsible for mediating the eﬀect of insulin
on the cell. In the vascular endothelial cell there are 2
competing pathways, both activated by insulin binding. The
predominant pathway is the PI3K pathway [28]. This path-
way activates the enzyme endothelial nitric oxide synthetase
(ENOS). ENOS catalyzes the conversion of the amino acid
L-Arginine to L-Citrulline producing, as a byproduct, nitric
oxide [29]. Nitric oxide, in itself, is a free radical and causes
relaxationinvascularsmoothmuscle.Thiscausesanincrease
in blood ﬂow in the skin and other organs as needed for
metabolism,orascommonlyseenintheskin,increasingheat
loss from the body [30, 31].
In diabetes, the damage to the PI3K pathway is believed
t ob ed u et oe l e v a t e db l o o dg l u c o s ec o n c e n t r a t i o n sa b o v e
120mg/dL[26,32,33].Evidenceshowsthatspikesinglucose
during a given 24-hour period also cause signiﬁcant damage
to the insulin transduction mechanism in the cells and may
be more important than the average blood glucose [34, 35].
The exact relationship between these variations in blood
glucose and endothelial dysfunction has not been clearly
shown [32, 36–39]. Tissue studies have shown that, if 2
individual populations of cells are exposed to glucose, where
the average glucose is the same but in one set of cells glucose
ﬂuctuates from highs to lows, there is more death of cells
than in the population where glucose is just maintained high
[35, 40–42]. Further, oxidative stress is much higher in the
population subjected to spikes [42].
This mechanism itself reduces the transport of glucose
into the cells under the control of insulin. Thus, cells shift
to metabolism of free fatty acids to provide energy from
metabolism for the cell. As free fatty acid metabolism
increases, so do free radicals and the release of inﬂammatory
cytokines [43, 44]. These cytokines and free radicals damage
the cell even further by both increasing insulin resistance
through glycosylation end products, damaging the insulin
receptor even further, and reducing the bioavailability of
nitric oxide as a mediator of vasodilation [45]. High concen-
trations of free radicals in the cellhave been shown to oxidize
nitric oxide released from endothelial cells into a superoxide,
peroxynitrite. This superoxide has no biological eﬀect on
vascular smooth muscle [37, 46, 47]. Further, in addition
to nitric oxide eliciting vasodilation, a second vasodilator
pathway in blood vessels, prostacyclin (prostaglandin I2)i s
also damaged by free radicals [48]. The reduced vasodilators
intissuescausevasoconstrictionofthebloodvesselstotissue,
making the cells anoxic and releasing more free radicals [48].
This cyclic process accelerates and increases damage to cells
over time until severe damage to the endothelial cells is
seen.
A second pathway contributes to vasoconstriction well.
As cited above, the main eﬀect of insulin binding to the cells
isactivationofthePI3Kpathway[49].Thispathwaycatalyzes
the release of nitric oxide from cells so that as more glucose
metabolism can take place, blood vessel dilation increases
oxygen delivery and removes carbon dioxide from the
increased metabolism in the cell. But, a competing pathway
is also seen in the cell. Normally a minor pathway, the
mitogen-activated protein kinase (MAPK)signaling pathway
is activated in diabetes [50]. Whereas insulin causes vasodi-
lation due to the PI3K pathway, it causes vasoconstriction in
the MAPK pathway. The impairment in the PI3K pathways
in diabetes shifts the eﬀect of insulin, rather than causing
vasodilationofbloodvessels,tovasoconstriction,makingthe
cell even more anoxic [50].
In addition to the increased vasoconstriction and in-
creased free radicals in the cells associated with damage to
thePI3KpathwayandactivationoftheMAPKpathway,there
are morphological changes in the endothelial cell. Normally,
vascular endothelial cells have electrotonic connections
to the surrounding vascular smooth muscles [46]. When
endothelial cells increase their potassium permeability they
hyperpolarize. As a result, these electrotonic connections
to smooth muscle contribute to the relaxation of vascular
smoothmuscle[51,52].Thiselectricalconnectionaidsinthe
hyperpolarization and relaxation of vascular smooth muscle
to increase vasodilation. However, in Type 2 diabetes, these
electrical connections are impaired [17, 51, 53]. Studies on
rat retinal preparations of these gap junctions show that
the principal gap junction protein, connexin 43 but not 37
and 40 is downregulated by incubation of these cells with
high glucose media [54]. This may or may not pertain to
vascular endothelial cells in the skin, but poses an interesting
possibility.
Partially through glycosylation end products, and partly
through impaired circulation (enhanced vasoconstriction),
there is damage to the sympathetic nervous system that leads
to a reduced blood ﬂow response to stressors in organs such
as the skin. Autonomic damage occurs to the sympathetic
ganglia and neurons even at the time of the clinical diagnosis
of diabetes [18, 37, 55–60]. A common clinical measure
of autonomic nervous system impairment is heart rate
variability with the subject at rest. Normally, vasomotor
rhythm in the sympathetic and parasympathetic systems
causes the heart rate to vary continuously at rest [6, 37, 61].
These variations in heart rate can be seen by a frequency
analysis of the EKG. As diabetes progresses, heart rate var-
iability is reduced such that ﬁnally, sympathetic damage
and parasympathetic damage have occurred to the extent
that there is very little variation in heart rate with normal
respiration or even a change in body position [37, 57, 61].
In addition, damage to tactile sensory nerves as well as to
autonomic nerves in the skin contributes even more to the
reduction in function seen in the autonomic nervous system
[62].Experimental Diabetes Research 3
3. The Effect on Local Pressure
The predominance of vasoconstrictors over vasodilators
released from vascular endothelial cells in people with dia-
betesandolderindividualscausesskinbloodﬂowtobelower
at rest in people with diabetes than in age-matched controls
compared to younger people [29]. Numerous studies have
shown resting skin blood ﬂow to be as little as one third (1/3)
that of age-matched controls [56, 63–66]. Making matters
worse,variousprotectivemechanismsinthebodyatthelevel
of the vascular endothelial cell are also damaged in diabetes.
One of these is the response to local pressure. When standing
on the feet, the pressure on the skin tends to impair the
circulation. To prevent this, skin vertical pressure receptors
are involved in eliciting vasodilation of the skin. When light
pressure (up to 4Kpa) is applied to the skin, there is an
increase in skin blood ﬂow [67–70]. When pressures as high
as22Kpaareappliedtotheskin,bloodﬂowinitiallyincreases
as pressure increases and then eventually by pressures of
2 2 K p at h eb l o o dﬂ o wi so c c l u d e d[ 67, 70]. For a normal
weight person standing on their feet, the pressure on the
feet is approximately 15Kpa [42]. Thus, for the average
person, skin blood ﬂow increases as they stand increasing
perfusion and protecting the skin of the feet from damage.
The mechanism is largely related to nitric oxide release.
It is not surprising, then, with impairment in nitric oxide
pathways due to free radicals and damaged endothelial nitric
oxide synthetase, that the pressure response is also reduced.
Inpeoplewithdiabetes,pressuresofonly4Kpaoccludemost
blood ﬂow, and pressures of only 2Kpa cause a mild decrease
in skin blood ﬂow. Thus, by the time pressure reaches
7Kpa, blood ﬂow is totally occluded [71, 72]. Thus, for the
average individual of normal weight, what this means is that
when standing, skin blood ﬂow is occluded. For someone
with diabetes, due to the usual higher incidence of obesity,
pressures are even higher and can range to over 30Kpa on
the skin of the feet and blood ﬂow is absent from the skin
during standing. This occlusion of the circulation during
quite standing as well as during movement adds to possible
circulatory damage, and, when lesions occur to the skin,
healing is severely impaired [73].
An additional mechanism is that when pressure is
removed from the skin, there is a large reactive hyperemia
that washes out metabolites and restores oxygen supply
[74]. This reactive hyperemia is not present in people with
diabetes. Even when the pressure is removed recovery from
the anoxia takes a much longer period of time [74, 75].
4. Response to Occlusion
Occlusion of the circulation occurs during normal daily
activities. For example, at night, rolling on an arm or
leg often results in occlusion of the circulation. This also
occurs when changing body positions while sitting in a
chair and leaning at various angles, or even, to some extent
during exercise. Isometric exercise for example (to be dis-
cussed later) results in occlusion of the circulation in muscle
during the exercise. Normally, as shown in Figure 1, the
response to occlusion is, depending on the length of the
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Figure 1: This ﬁgure shows the blood ﬂow recorded for 2 minutes
following the release of an arterial occlusion cuﬀ on the brachial
artery in young controls (triangle), nondiabetic age-matched
controls (squares), and subjects with type 2 diabetes (diamonds).
I l l u s t r a t e dh e r ea r et h ea v e r a g er e s u l t sf o r1 5s u b j e c t si ne a c h
group ±standarddeviation.Bloodﬂowsareexpressedincc/100mL
muscle per minute and the time scale on the bottom is in minutes.
Bloodﬂowsarerecordedevery12secondsstartingat3secondsafter
occlusion (from [56]).
occlusion, a hyperemia after the blood ﬂow is restored. The
magnitude of the hyperemia in younger individuals can be
very pronounced.
For example, for whole arm blood ﬂows measured
by volume plethysmography, resting blood ﬂow normally
averages 3 or 4cc’s per 100 grams tissue per minute. If
occlusion is maintained for 4 minutes (a standard measure
of vascular endothelial function used clinically) and then the
occlusion is released, blood ﬂow in a younger individual can
i n c r e a s et ow e l lo v e r7 5c c ’ sp e r1 0 0g r a m st i s s u ep e rm i n u t e
in the ﬁrst few seconds, and then after 2 minutes return back
to normal [65, 76]. This exponential decrease in blood ﬂow,
as shown in Figure 1, is characteristic of younger individuals
and, to a larger extent, older individuals. During the period
that blood ﬂow remains high, metabolites are washed from
tissue and oxygen is rapidly restored protecting the tissue
from damage and preparing it to return to normal activity
[19, 26]. In older individuals, as also shown in Figure 1, the
magnitude of the reactive hyperemia is only 25cc’s per 100
grams tissue per minute. The hyperemia then, as was the
case for younger individuals, returns within a few minutes
back towards the normal resting blood ﬂow. However, for4 Experimental Diabetes Research
people with diabetes, as shown in this ﬁgure, blood ﬂow is
barely above rest after the occlusion is removed even after 4
minutes of occlusion. After 2 minutes after occlusion, blood
ﬂow is restored once again to a level at about 25 or 30%
thatofthenormalage-matchedcontrolledindividuals.These
diﬀerences between the 3 groups of subjects was signiﬁcant
at all times from rest to 2 minutes postocclusive hyperemia
(ANOVA P<0.05). Recent evidence shows that nitric
oxide is only a minor contributor to the mechanism for
postocclusive hyperemia [77]. Thus, the reason it is impaired
with ageing and diabetes is also only poorly understood.
However, the clear eﬀect of aging and diabetes can easily
be seen in Figure 2. As shown in Figure 2, if the area
under the entire 2 minute postocclusive curve in Figure 1 is
calculated as a single number (excess blood ﬂow needed after
occlusion) and is plotted on a graph in relation to age, the
top line in the ﬁgure shows the reduction in postocclusive
hyperemia associated with the aging process. The second
line on the ﬁgure, the squares, shows an equivalent line
for people with diabetes starting at age 20 to age 80. Over
this age range, while the line is parallel to that of age-
matched controls, it is at several levels of magnitude lower
showingtheadditionaldamagetoocclusioncausedinpeople
with diabetes. However, if shear response is related to post-
occlusive hyperemia, it maybe mediated by a prostaglan-din-
mediated mechanism.
5.LocalHeat
The reaction of tissue to an increase in tissue temperature,
like the reaction to skin pressure, is mediated by the
vascular endothelial cell [26, 29, 30]. The blood ﬂow increase
associated with local heat is a biphasic response. There
are 2 pathways involved. When heat above 42◦Ci sa p p l i e d
to the skin, it immediately (phase 1) responds with a
rapid increase in circulation. This increase in circulation is
mediated by skin sensory nerves. The sensory nerves release
substance-P and Calcitonin-gene-related peptide (CGRP)
[78–82]. These substances diﬀuse laterally from the sensory
nerves causing an increase in circulation by relaxing vascular
smooth muscle around blood vessels. This protects the skin
from rapid changes in temperature that might cause damage
[30, 83]. In skin tactile sensory nerves, TRPV1 voltage-
gated calcium channels are responsible for releasing these
substances [84]. However, this is short lived. Skin sensory
receptors accommodate and soon lose their ability to sustain
vasodilation [50]. As they do, the skin vascular endothelial
cells begin to release nitric oxide. Endothelial nitric oxide
synthetase has a calcium-binding domain [29, 33, 35, 85].
Intracellular calcium, released by temperature sensitive ion
channels in the cell membrane (TRPV4), activates the
enzyme ENOS and thus elicits the production of nitric oxide
in vascular endothelial cells [26, 86, 87]. In people with
diabetes, as cited above, resting blood ﬂow is much lower
than in age-matched controls. Also, with the nitric oxide
pathway being damaged through oxidation of nitric oxide
[88] or lack of production of nitric oxide, or in some cases
under bioavailability of L-Arginine as the precursor to nitric
oxide in people with diabetes, the skin blood ﬂow response
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Figure 2: This ﬁgure illustrates the excess blood ﬂow above rest
during a two-minute period after the release of an occlusion cuﬀ
on the brachial artery of age-matched control subjects and subjects
with diabetes. Individual data points are shown for control subjects
(diamonds) and subjects with diabetes. For the control subjects
the regression line was Blood Flow = −0.518 age + 77.78. For the
subjects with diabetes the regression equation was Blood Flow =
−0.253 age + 31.01 [65].
is greatly diminished with heat [89–91]. Associated with
diabetesareelevatedlevelsofasymmetricaldimethylarginine
(ADMA). This competes with l-arginine for a binding site
on ENOS reducing production of nitric oxide form vascular
endothelial cells [92]. Arginine supplements can compete
with ADMA reducing endothelial dysfunction [92]. The
impairment in skin blood ﬂow with local heat in people with
diabetes can be seen in Figure 3.
In Figure 3, when the skin blood ﬂow response to heat
at 42◦C is examined, the blood ﬂow response in people with
diabetesissubstantiallylowerthanage-matchedcontrols[93,
94].
This occurs in both the ﬁrst and second phase of the
blood ﬂow response to heat. Even more interesting is the
calories transferred through the skin. When the relationship
between skin blood ﬂow and heat gained by the skin in
young, older, and subjects with type 2 diabetes is examined,
it can be clearly seen that to warm the skin to the same
temperature, people with diabetes take a fraction of the
calories to warm the skin as is seen in either young subjects
or age-matched controls [63, 64, 89, 96]. One of the
contributors to this is the fact that skin structure is also
diﬀerentinpeoplewithdiabetes[97].Thinnerskinandmore
subcutaneous insulation impair the conductive heat loss
through the skin to an applied thermal load. Skin thickness
varies in diﬀerent parts of the body. The thermal coeﬃcient
of the skin is much lower than that seen in age-matched
controls without diabetes [97, 98]. The skin temperature
rises faster in people with diabetes when a constant heat
source is applied due to circulatory impairment. This, in
turn,allowstheskintooverheat.Itisnotsurprisingthenthat
in Figure 4, it takes fewer calories in older people and people
with diabetes to heat the skin.
The overall eﬀect of this is that older people and people
with diabetes are more susceptible to burns. Since the
principal means of removing heat from the skin is the
circulation when a warm heat source is applied [97], it is
no surprise that people with diabetes are more susceptible toExperimental Diabetes Research 5
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Figure 3: The blood ﬂow response to a local heat source applied
to the forearm in 10 subjects with diabetes and 10 age-matched
controls over a 20-minute period. Each point is the mean do 10
subjects ± the SD (from [71, 95]).
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Figure 4: Illustrating the relationship between skin blood ﬂow
and heat gained by the skin in young subjects, older subjects, and
subjects with type 2 diabetes. Average ± the SD for each group
is shown (n = 15). Experiments involved adding calories of heat
to the skin by applying a brass 50 gram heated block at diﬀerent
temperatures and measuring the change in skin blood ﬂow for
ag i v e nc a l o r i cl o a d[ 99, 100]. The diﬀerence in heat absorbance
between the 3 groups was signiﬁcant (ANOVA P<0.05).
burns than are age-matched control subjects [101]. Another
contributor to the poor thermal response of the skin in
people with diabetes is drier skin. Skin moisture content
is about half that of age-matched controls in people with
diabetes [98]. When the skin is dry, the blood ﬂow response
to heat is less, presumably due to TRPV-4 osmotic receptor
interaction with normal ENOS activation pathways [97, 98].
The same TRPV-4 channels that sense heat on endothelial
cells also sense blood and skin osmolarity. When skin is dry,
the channels show a diminished response to heat [102]. This
is worse in people with diabetes. Even when a moist heat
source is used on people with diabetes, the heat tolerance
is still less for hot packs compared to age-matched controls
[97, 98].
Another contributor to the diminished response of the
skin to local heat is damage to sweat glands. Associated with
diabetes,andtoamuchlesserextentaging,sweatglandshave
a reduced output and, in diabetes, are eventually destroyed
[59]. This impaired pseudomotor response starts usually in
the periphery such as the feet and then spreads throughout
the body [18]. Since sweat glands are both apocrine and
eccrine, it is not just the lack of sweat that becomes an issue
for diabetes in that without adequate sweat the skin does
not cool as fast, but since apocrine sweat glands provide oil
for lubrication of the skin, the skin is even drier than that
associated with aging [103].
6.Contrast Baths
Contrast baths are a good example of how impaired
endothelial function impairs the response to heat. Beginning
with the Greeks and Romans, contrast baths have been
used in therapy [6, 104, 105]. The theory behind contrast
baths is that by alternating hot and cold using a ratio of
approximately 3 minutes in a hot bath to 1 minute in a cold
bath, that there will be a greater increase in skin circulation
than with a warm bath alone [6, 104]. The enhanced blood
ﬂow response is alleged to cause greater removal of waste
products from the skin than simple placement of the skin in
a local warm bath [105]. When young subjects place their
legs in contrast baths with a ratio of 3 minutes of warm to 1
minute of cold, the overall result is a much greater increase
in skin blood ﬂow than can be achieved by just leaving the
leg in a contrast bath of the same temperature continuously.
The oscillation in skin blood ﬂow associated with placing
the limb in alternating hot and cold baths compared to the
sustained increase in blood ﬂow with emersion of constant
heat [6, 104]. However, while this same phenomenon holds
toalesserextentinolderindividuals,inpeoplewithdiabetes,
contrast baths cause a smaller overall blood ﬂow response in
the skin than with a continuous warm bath. Thus for people
with diabetes they provide a negative therapeutic eﬀect. This
is illustrated in Figure 5 (controls) and people with diabetes
(Figure 6). Note the higher average blood ﬂow above that of
continuous heat in the age-matched controls but not in the
subjects with diabetes [6].
7.Global Heat
The endothelial response to pressure, occlusion, and local
heat shows a clear defect in the control of circulation. It is
of no surprise then that when looking at more grandiose
control where the sympathetic nervous system is needed to
coordinate the body, the eﬀects of age and diabetes are more
pronounced. The response to global heat is mediated by
the circulation and sweat. When subjects are exposed to a
hot room, the sweat response is greatly diminished in older
subjects compared to younger individuals [18]. The sweat
rate is approximately 70% of that in age-matched controls.6 Experimental Diabetes Research
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Figure 5: This ﬁgure illustrates the blood ﬂow in the skin (ﬂux)
measured over the experimental period in control subjects during
immersion in contrast baths (triangles), continuous heating (dia-
monds), and continuous cold immersion (squares). All data is the
mean ± the SD [106, 107].
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Figure 6: This ﬁgure illustrates the blood ﬂow in the skin (ﬂux)
in subjects with diabetes during immersion in contrast baths (tri-
angle), continuous hot (diamond), and cold immersion (squares)
[106, 107].
It has been known for many decades that the sweat rate is
lower and sweat gland density is lower in older compared to
younger individuals [108]. When subjects are exposed to a
hot room, the blood ﬂow response is also greatly diminished
compared to age-matched controls or younger individuals
[18]. The lower resting skin blood ﬂow due to age and
lower blood ﬂow response to heat, as was described above
in the response to local heat, allows skin temperature to
become elevated as is central body temperature in response
to heat [108–111]. Plasma volume percent decrease during
heat exposure was also greater in older than younger people
[110]. It is not surprising that older individuals are more
susceptibletohyperthermiaaswell[112].Further,totalsweat
sodium loss increases with age [112].
Autonomic impairment, common in diabetes [24], alters
both the blood ﬂow response to global heat and the sweat
response to global heat. Numerous studies have shown that
people who have diabetes have impaired response to whole
body(global)heating[59,113,114].Atrest,thelowerresting
skin blood ﬂow lowers skin temperature compared to age-
matched controls [115]. But when subjects are exposed to
a hot room, the blood ﬂow response and sweat response
are greatly diminished compared to age-matched controls
or younger individuals [18, 26]. The reduced sweat rate in
people with diabetes is related to low nitric oxide production
in sweat glands and high concentrations of free radicals
in the blood [116]. This same study related autonomic
nerve dysfunction to this same concentration of high free
radicals [116]. These investigators show that Glutathione, a
potent antioxidant in cells, is generally depleted in people
with diabetes [117] and may allow enhanced nitric oxide
production to increase free radicals in the cells and lead to
autonomic neuropathy. Because of impairment in sweating,
skin temperature is elevated far above that seen in younger
or older individuals as is rectal temperature [118].
8. Orthostatic Tolerance
Blood pressure is normally well regulated in the body.
Changes in posture usually cause a small and transient
change in blood pressure [119, 120]. The most common
test is the head up tilt test to 70◦C[ 121]. If blood pressure
drops more than 20mmHg for 1 minute after going from a
seated to standing position, the World Health Organization
classiﬁes this as orthostatic intolerance [122]. Orthostatic
tolerance can also be measured by measuring the blood
pressure response to standing from a seated position or from
a lying position. A more radical stress is by having someone
squat and then stand [119, 120]. Another laboratory-based
measure is to use lower body negative pressure to induce a
change in blood pressure [123]. Aside from the obvious risk
of falling in the elderly, orthostatic hypotension is associated
with cardiovascular mortality and all-cause mortality [124].
Orthostatic tolerance decreases with both age and diabetes
[125–128].
Normallywhenstandinguprightthereisdecreasedblood
pressure,andastheautonomicnervoussystemcompensates,
the blood pressure comes back towards normal [122, 129].
Thisisachievedbyanincreaseinperipheralvasoconstriction
a n da ni n c r e a s ei nh e a r tr a t e .I no l d e rp e o p l ea n dp e o p l e
with diabetes, there is a reduction in heart rate variability
caused by reduced control of both the sympathetic and
parasympathetic nervous systems [130, 131]. It is of no
surprise then that orthostatic tolerance is also reduced
in older people and people with diabetes due to loss of
autonomic control. In many people with diabetes, we have
observed no change in heart rate when changing body
position [132, 133]. The reduced heart rate variability shows
impairment in autonomic function in these groups [130].
Some of the deﬁcit in autonomic function has been linked
to ganglionic damage [134]. Autonomic neuropathy is also
commonwithageanddiabetes[135].Thereissomeevidence
that there is reduced baroreceptor sensitivity with ageing and
diabetes possibly due to increased angiotensin II activity due
to increased renin release form the kidney [136].Experimental Diabetes Research 7
In people with diabetes, in many studies, there is con-
ventionally about 25% of the population that have ortho-
static tolerance deﬁned by the World Health Organization.
However, in recent studies, we found that if the room is
ﬁrst warmed to 39◦C and subjects are warmed in the room
for 20 minutes, upon standing, 100% of the people had
orthostatic intolerance [122]. This has been conﬁrmed in
other studies [123, 137]. Thus, it appears that when stressors
are combined, the autonomic nervous system cannot handle
the combined load of a thermal stress and an orthostatic
stress together, and all people with diabetes seem to have
orthostatic intolerance. In younger controls, there is enough
reserve in the cardiovascular system to accommodate 2
simultaneous stressors.
9.IsometricExercise
Isometric exercise is a type of exercise where force is exerted
by the muscle but the muscle does not change length [138,
139]. With impaired neurogenic control of the circulation
in muscle, impaired local control of the circulation and
impaired sweating, the cardiovascular response to isometric
exercise is also impaired in people with type 2 diabetes
compared to age-matched controls [59, 140]. For example,
looking at endurance and recovery of endurance, if 2
isometric contractions are accomplished 10 minutes apart,
the endurance for the ﬁrst contractions is similar in an age-
matched control group than in people with diabetes [141,
142]. However, for the second contraction the endurance in
the group of diabetes is much shorter showing a prolonged
recovery time, and when blood ﬂow is measured lower
blood ﬂows are found during and after exercise in people
with diabetes compared to age-matched controls [59, 140].
During the exercise, traditionally blood pressure increases
(both systolic and diastolic) driven by high sympathetic
outﬂow. In people with diabetes, resting blood pressure is
higher as is the blood pressure response to the exercise. Since
the heart rate change and heart rate variability are both
reduced with ageing and diabetes, the higher blood pressure
response is driven by higher total peripheral resistance,
increasing stroke work considerably [142–144]. Sympathetic
impairment also reduces the sweating response to isometric
exercise [59]. For dynamic exercise, strength is generally less
and endurance is less for either kinetic or dynamic exercise.
Thus, for people with diabetes, exercise performance and the
cardiovascular responses are both aﬀected by diabetes.
10.Balance
One of the most pronounced eﬀects of diabetes is on balance
and gait. Balance and gait are both contributed to by the
vestibular system, the eyes, and proprioceptive system in
the legs [57, 145]. All 3 are important in allowing someone
to balance themselves and to walk properly. With diabetes,
with diabetic polyneuropathies, there is impaired vestibular
function, impaired vision due to retinopathies, and impaired
somatosensory input into the vestibular nuclei [57]. It is
of no surprise then that there are balance impairments in
people with diabetes. During quite standing and during
movement balance is impaired [146, 147]. Incorrect visual
cues simply make matters worse. Thus, in dim light, poor
visual cues make balance even worse in people with diabetes
[148]. People with diabetes have better balance in a totally
dark room because they do not confuse incorrect visual cues
andhampertheirabilitytobalance.Further,thecoloroflight
seen by the eyes shows the greatest impairment with diabetes
in the blue range, the very color that most night lights are
[148].Inanotherstudy,theautonomicresponse tobalanceis
also impaired in people with diabetes. Thus, for people with
diabetes, there is an abnormally low heart rate and blood
pressure response to allow the body to be maintained stable
during balancing attempts, making balance even worse [26].
These all have a pronounced impact on gait. In general,
people with diabetes, because of lack of feeling and pro-
prioceptive sense and poor balance, have slower gait and
maintain a wider balance for postural support during gait.
Further, during gait they circumduct thus having the legs
furtheraparttobeabletocatchtheirbalanceifthetriporfeel
unsteady during gait [149]. This slows gait down about 30%
in people with diabetes compared to age-matched controls
subjects.
11. Summary
In summary, for older individuals and people with diabetes
there are multiple impairments in the autonomic nervous
system that aﬀect activities of daily living from very simple
ones, such as response to local heat or the pressure on
the feet during standing leading to increased possibilities of
burnsandskindamage,tomorecomplexmovementssuchas
balance and gait which are substantially impaired in people
with diabetes. Patients must be counseled during therapy,
relative to these impairments, so as to protect them as they
carry out their normal daily life activities.
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